CRISPR-Cas12a

Overview

CRISPR-Cas12a is an RNA-guided DNA endonuclease used in the CRISPR-Cas gene-editing and molecular diagnostics toolkit. Like other CRISPR-Cas systems, it originates from prokaryotic adaptive immunity, where CRISPR-associated proteins help bacteria and archaea recognize and destroy invading genetic material. In biotechnology, Cas12a is valued for its programmable targeting by a CRISPR RNA (crRNA), its preference for thymine-rich protospacer adjacent motifs, and its ability to generate staggered 5' DNA breaks rather than the blunt cuts associated with Cas9.

A distinctive feature of Cas12a is collateral, or trans, cleavage of single-stranded DNA after target recognition. This property has made CRISPR-Cas12a especially useful in biosensing platforms, where target binding can be converted into a detectable signal. Its simplified guide RNA architecture and compatibility with diverse genome editing and diagnostic workflows have also made it an important platform in precision biotechnology, including cancer research, infectious disease detection, food safety testing, and emerging therapeutic genome editing.

Focus of Latest Publications

Recent publications portray CRISPR-Cas12a as both a genome-editing effector and a diagnostic signal amplifier. A 2026 review on programmable spatiotemporal control emphasized that Cas12a offers several practical advantages over Cas9, including recognition of thymine-rich PAMs, staggered 5' DNA cleavage, simplified guide RNA design, and collateral single-stranded DNA cleavage. Another review on CRISPR-Cas12a biosensing described it as a versatile biotechnology platform with major applications in biosensing, diagnostics, and precision genome editing.

Several studies focused on diagnostic assays that coupled CRISPR-Cas12a with nucleic acid amplification. One report developed a CVA16 detection platform by combining reverse transcription multiple cross displacement amplification with CRISPR-Cas12a-based biosensing. Another used photoactivated digital recombinase polymerase amplification with CRISPR-Cas12a for point-of-care quantification of BK polyomavirus, highlighting the DETECTR-style advantage of combining amplification with Cas12a-mediated detection for digital nucleic acid analysis. A food-safety study integrated LAMP with CRISPR/Cas12a and a fork-shaped enhanced probe, using lateral flow testing to detect Listeria monocytogenes without equipment. Similarly, a thermal-optimized PCR assay coupled with CRISPR-Cas12a fluorescence detection for blaOXA-1-harboring E. coli isolates, showing that Cas12a can be incorporated into rapid resistance-gene testing workflows.

Other studies extended Cas12a biosensing into electrochemical, colorimetric, fluorescence polarization, and aptamer-based formats. A dual RAA-CRISPR-Cas12a method was reported for sensitive and specific identification of Burkholderia gladioli and its toxigenic subspecies in food. An environmentally resilient sensing reactor armored with a metal-organic framework was designed to improve the stability of Cas12a-based detection of Salmonella typhimurium under challenging conditions, addressing the known sensitivity of Cas enzymes to temperature fluctuations and organic solvent interference. Another study used a CRISPR-Cas12a-based electrochemical method for detection of Burkholderia gladioli in fresh noodles and tremella. Additional work described a Cas12a-powered aptasensor for gastric cancer extracellular vesicles, a rigidity-responsive fluorescence polarization strategy for aflatoxin B1 detection, and a dual CRISPR-Cas12a signal-amplification system for microplastic recycling and visual prediction. These studies collectively show Cas12a being paired with aptamers, rolling circle amplification, magnetic complexes, and smartphone or deep-learning readouts to improve sensitivity and portability.

Cas12a was also used in studies aimed at improving catalytic performance and assay robustness. One crRNA-engineering strategy increased the trans-cleavage catalytic efficiency of Cas12a by 33%, leading to an enhanced RPA-ECas12a system for Lactiplantibacillus plantarum detection. This illustrates how guide RNA design can tune Cas12a activity for ultrasensitive detection. Another study on spatiotemporal control of Cas12a framed the enzyme as a platform for precision engineering in next-generation gene editing and diagnostics, reinforcing the importance of chemically inducible systems and other control strategies for regulating activity.

In therapeutics, CRISPR-Cas12a appeared in investigational gene-editing approaches for hemoglobinopathies. Two New England Journal of Medicine reports described renizgamglogene autogedtemcel, an investigational autologous hematopoietic stem-cell therapy using CRISPR-Cas12a editing of the HBG1 and HBG2 promoters for β-thalassemia and sickle cell disease. These studies place Cas12a within the broader field of DNA editing and base/prime editor development for inherited disease, alongside other CRISPR-derived technologies. More generally, recent reviews on DNA and RNA editing and on gene editing for haemophilia and epilepsy situate CRISPR platforms, including Cas12a, within a rapidly expanding therapeutic landscape that also includes adenine base editor systems and other precision genome-engineering tools.

Across the cited literature, CRISPR-Cas12a is therefore presented as a flexible platform bridging genome editing and diagnostics. Its use spans cancer-related biosensing, infectious disease detection, food safety, environmental monitoring, and clinical gene editing, often in combination with lipid nanoparticles, gold nanoparticles, chimeric antigen receptor-related contexts, and other Gene Editing Technologies used to improve delivery, specificity, or readout.

Key Publications

• May Thermal optimized PCR coupled to CRISPR-Cas12a for rapid detection of blaOXA-1 resistance gene. (PloS one, 2026, PMID 42139236): "we optimize a rapid molecular assay combining a PCR with modified thermal ramp rate (TRR) along with CRISPR-Cas12a fluorescence detection for blaOXA-1-harboring E. coli isolates."
• May Photoactivated Digital Recombinase Polymerase Amplification/CRISPR-Cas12a Assay for Point-of-Care of BK Polyomavirus Quantification. (ACS nano, 2026, PMID 42003707): "The combination of CRISPR-Cas12a with recombinase polymerase amplification (RPA), termed DETECTR, offers notable advantages for digital nucleic acid analysis."
• May Rapid and Specific Detection of Gastric Cancer EVs Using a Cas12a-Powered Aptasensor with a Novel Targeting Aptamer. (Analytical chemistry, 2026, PMID 42011754): "Subsequently, this aptamer was incorporated into a CRISPR-Cas12a-based biosensor."
• May A Rapid and Ultrasensitive Detection of Coxsackievirus A16 Using Reverse Transcription Multiple Cross Displacement Amplification Combined with the CRISPR-Cas12a-Based Biosensing System. (ACS infectious diseases, 2026, PMID 42024482): "Herein, a diagnostic platform for CVA16 (CVA16-RT-MCDA-CRISPR) was developed by combining reverse transcription multiple cross displacement amplification (RT-MCDA) with CRISPR-Cas12a-based detection."
• May crRNA-engineered CRISPR/Cas12a system coupled with RPA for ultrasensitive detection of Lactiplantibacillus plantarum. (Food chemistry, 2026, PMID 41762887): "...an enhanced CRISPR/Cas12a system (termed RPA-ECas12a) was developed for the detection of Lactiplantibacillus plantarum."
• May CRISPR/Cas12a and fork-shaped probe enhance LAMP-LFT integration for equipment-free detection of Listeria monocytogenes. (Food research international (Ottawa, Ont.), 2026, PMID 41794473): "(2) LAMP combined with CRISPR/Cas12a, using LFT to detect a cleaved fork-shaped enhanced probe labeled with three fluoresceins."
• May A ∆ssaV deletion attenuates Salmonella Choleraesuis to generate a self-limiting, immunogenic vaccine candidate. (Vaccine, 2026, PMID 41930529): "The ssaV gene, a key component of the SPI-2 T3SS, was knocked out to construct a vaccine candidate designed to strike an optimal balance between attenuation and immunogenicity using CRISPR-Cas9."
• Apr Is the alpha-amylase paralogue Amyrel dispensable in Drosophila melanogaster? (Open biology, 2026, PMID 42049209): "To get an insight into Amyrel function, we knocked out the gene using CRISPR-Cas9."
• Apr Clustered Regularly Interspaced Short Palindromic Repeat-Based Colorimetric Aptasensor Combined with Smartphone Imaging and Deep Learning Enables Selective Recycling and Visual Prediction of Microplastics in the Environment. (Analytical chemistry, 2026, PMID 41964558): "Upon microplastic binding, a competitive reaction releases an activator DNA, initiating a dual CRISPR-Cas12a system for signal amplification."
• Apr Rigidity-Responsive Fluorescence Polarization Detection of Aflatoxin B1 via Programmable RCA-Coupled CRISPR/Cas12a and a Conformation-Restricted Depolarization Reporter. (Analytical chemistry, 2026, PMID 41993032): "Herein, we propose a rigidity-responsive fluorescence polarization (FP) biosensing strategy that integrates aptamer-based molecular recognition, rolling circle amplification (RCA), and CRISPR/Cas12a trans-cleavage for robust and matrix-tolerant AFB1 detection."